- Home
- NNOX vs GALT Comparison
NNOX vs GALT Comparison
Compare NNOX & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNOX
- GALT
- Stock Information
- Founded
- NNOX 2011
- GALT 2000
- Country
- NNOX Israel
- GALT United States
- Employees
- NNOX N/A
- GALT N/A
- Industry
- NNOX Medical Electronics
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- NNOX Health Care
- GALT Health Care
- Exchange
- NNOX Nasdaq
- GALT Nasdaq
- Market Cap
- NNOX 253.8M
- GALT 232.3M
- IPO Year
- NNOX 2020
- GALT N/A
- Fundamental
- Price
- NNOX $4.33
- GALT $4.74
- Analyst Decision
- NNOX Strong Buy
- GALT Strong Buy
- Analyst Count
- NNOX 2
- GALT 3
- Target Price
- NNOX $8.50
- GALT $6.00
- AVG Volume (30 Days)
- NNOX 1.3M
- GALT 367.3K
- Earning Date
- NNOX 11-20-2025
- GALT 11-12-2025
- Dividend Yield
- NNOX N/A
- GALT N/A
- EPS Growth
- NNOX N/A
- GALT N/A
- EPS
- NNOX N/A
- GALT N/A
- Revenue
- NNOX $11,886,000.00
- GALT N/A
- Revenue This Year
- NNOX $20.50
- GALT N/A
- Revenue Next Year
- NNOX $64.10
- GALT N/A
- P/E Ratio
- NNOX N/A
- GALT N/A
- Revenue Growth
- NNOX 17.36
- GALT N/A
- 52 Week Low
- NNOX $3.60
- GALT $0.73
- 52 Week High
- NNOX $11.00
- GALT $6.55
- Technical
- Relative Strength Index (RSI)
- NNOX 50.50
- GALT 63.90
- Support Level
- NNOX $3.60
- GALT $4.10
- Resistance Level
- NNOX $4.15
- GALT $5.06
- Average True Range (ATR)
- NNOX 0.17
- GALT 0.28
- MACD
- NNOX 0.05
- GALT -0.02
- Stochastic Oscillator
- NNOX 66.67
- GALT 72.92
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.